CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Pal Pacher

OPENALEX: A5084119264↗ORCID: 0000-0001-7036-8108↗

Affiliations

Organizations

National Institute on Alcohol Abuse and Alcoholismauthorship · US National Institutes of Healthauthorship · US

Public evidence

7 connected articles

Selective Depletion of Gut Gram-Negative Bacteria Attenuates Alcohol Binge-Induced Cardiovascular Dysfunction by Lowering Cardiac Anandamide Levels.2026 · Europe PMC Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.2017 · Europe PMC Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.2017 · PubMed Central Open Access Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activity.2017 · Europe PMC Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.2013 · Europe PMC CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.2009 · Europe PMC Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells.2008 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Pal Pacher - Medical Cannabis Research Engine